fda bpc-157 ineligible for compounding 503a 503b Exciting news peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the Bulks List for use in compounding for FDA Peptide Compounding Status (2026)

Bacteriostatic Water Use 3 mL per 10 mg vial

Cagrilintide acts as a potent agonist at amylin receptors, which are heterodimeric complexes of the calcitonin receptor (CTR) and receptor activity-modifying proteins (RAMPs), primarily RAMP1, RAMP2, and RAMP3

Designed for delayed release in the lower intestines

When I got really good, the best I got at jiu-jitsu when I went from blue belt to purple belt was when I was training with Eddie, and we were drilling all the time

This increase in cAMP may activate protein kinase A (PKA), which then appears to phosphorylate hormone-sensitive lipase (HSL) on specific serine sites

Quad-agonist peptides (GLP-1/GIP/glucagon/GCG analogs): In preclinical development, these add galanin or other receptor targets to the triple-agonist backbone